Finoriq research workspace
ACHIEVE LIFE SCIENCES, INC. (ACHV) Institutional Holdings & 13F Ownership
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes. Review ACHV institutional holders, 13F ownership, and position changes on Finoriq.
Company Snapshot
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.
- Company
- ACHIEVE LIFE SCIENCES, INC. (ACHV)
- Ticker
- ACHV
- Market Cap
- $639.6M
- Latest Price
- $6.23
- Industry
- Diagnostics
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.